Dobutamine is used in cardiogenic shock to increase cardiac output. Its predominant mechanism of benefit is activation of which receptor?
- A Alpha-1 adrenoceptor, increasing systemic vascular resistance
- B Dopamine D1 receptor, causing renal vasodilation
- C Beta-1 adrenoceptor, increasing myocardial contractility ✓
- D Beta-2 adrenoceptor, causing bronchodilation
Explanation
Dobutamine is a synthetic catecholamine with predominant beta-1 agonist activity, producing positive inotropy with modest chronotropy and a slight decrease (via beta-2) in systemic vascular resistance—making it ideal in cardiogenic shock where raising contractility without markedly increasing afterload is desired. It does not act primarily on alpha-1 (minimal pressor effect) or D1 receptors (fenoldopam and dopamine at low dose mediate renal vasodilation via D1).
Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.